Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Polycythemia Vera × Erlotinib Hydrochloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 143 Lung Neoplasms 64 Pancreatic Neoplasms 40 Neoplasm Metastasis 20 Neoplasms 19 Brain Neoplasms 19 Breast Neoplasms 18 Head and Neck Neoplasms 17 Glioblastoma 15 Gliosarcoma 14 Adenocarcinoma of Lung 13 Squamous Cell Carcinoma of Head and Neck 11 Colorectal Neoplasms 9 Adenocarcinoma, Bronchiolo-Alveolar 9 Glioma 8 Carcinoma, Squamous Cell 7 Carcinoma, Hepatocellular 7 Esophageal Neoplasms 6 Carcinoma, Renal Cell 6 Astrocytoma 6 Rectal Neoplasms 5 Oligodendroglioma 5 Central Nervous System Neoplasms 5 Adenocarcinoma 5 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Liver Neoplasms 4 Gallbladder Neoplasms 4 Colonic Neoplasms 4 Breast Neoplasms, Male 4

Interventions

fludarabine phosphate 22 Cyclophosphamide 19 Peripheral Blood Stem Cell Transplantation 17 Busulfan 15 Whole-Body Irradiation 14 Mycophenolic Acid 12 ruxolitinib 11 Tacrolimus 11 Methotrexate 9 Cyclosporine 9 Antilymphocyte Serum 9 fludarabine 8 Melphalan 7 peginterferon alfa-2a 5 Aspirin 5 Stem Cell Transplantation 4 Radiotherapy 4 Filgrastim 4 Etoposide 4 Decitabine 4 Biopsy 4 Surveys and Questionnaires 3 Methylprednisolone 3 Injections 3 Imatinib Mesylate 3 Hydroxyurea 3 Flow Cytometry 3 Cytarabine 3 Blood Specimen Collection 3 Azacitidine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01038856 2020-08-24

OSI-TAR-766

University of Oklahoma

Phase 2 Terminated

5 enrolled 6 charts

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡